Top 10 Companies in the (S)-N-Fmoc-3-Bromophenylalanine (CAS 220497-48-3) Market (2026): Market Leaders Powering Global Peptide Innovation

MARKET INSIGHTS

Global (S)-N-Fmoc-3-Bromophenylalanine (CAS 220497-48-3) market size was valued at USD 38.2 million in 2025. The market is projected to grow from USD 40.6 million in 2026 to USD 68.4 million by 2034, exhibiting a CAGR of 6.7% during the forecast period.

(S)-N-Fmoc-3-Bromophenylalanine (CAS 220497-48-3) is a protected, non-natural amino acid derivative widely utilized in solid-phase peptide synthesis (SPPS). The compound features a 9-fluorenylmethoxycarbonyl (Fmoc) protecting group on the amine functionality and a bromine substituent at the meta position of the phenylalanine side chain, offering unique reactivity for further chemical modifications, including palladium-catalyzed cross‑coupling reactions. Its high stereochemical purity in the (S)-configuration makes it particularly valuable in the development of peptide-based pharmaceuticals, peptidomimetics, and specialty biochemical research applications.

The market is experiencing steady growth driven by rising demand for custom peptide synthesis in drug discovery, increasing adoption of non-natural amino acids in therapeutic peptide development, and expanding research activities across pharmaceutical and biotechnology sectors. Furthermore, the growing interest in bioconjugation chemistry and the synthesis of structurally complex peptide analogs continues to reinforce demand for specialized Fmoc-protected building blocks such as this compound. Bachem AG, Sigma‑Aldrich (Merck KGaA), and Iris Biotech GmbH are among the notable suppliers operating in this specialized segment.

(S)-N-Fmoc-3-Bromophenylalanine (CAS 220497-48-3) Market – View in Detailed Research Report

---

PRODUCT DEFINITION

As a halogenated, Fmoc-protected amino acid, (S)-N-Fmoc-3-Bromophenylalanine serves as a versatile building block for the synthesis of peptidomimetics, stapled peptides, and protein‑drug conjugates. The meta‑bromine provides a robust handle for post‑synthetic diversification via Suzuki, Sonogashira, or Negishi cross‑coupling, enabling rapid generation of structure‑activity relationship libraries and bioorthogonal labeling strategies.

---

Top 10 Companies

1️⃣ Bachem AG

Headquarters: Hürth, Germany
Key Offering: High‑purity, GMP‑grade (S)-N‑Fmoc‑3‑Bromophenylalanine (≥99% purity)

Bachem AG is a leading specialty chemical manufacturer with a dedicated amino acid division. Its state‑of‑the‑art asymmetric synthesis platform ensures >98% enantiomeric excess and rigorous purity controls, meeting the stringent requirements of pharmaceutical R&D and CDMO programs.

Sustainability & Growth Initiatives:

• Investment in green chemistry processes to reduce halogen waste
• Partnerships with academic institutions for early‑stage peptide pipeline development
• Expansion of GMP production lines to support global regulatory compliance

2️⃣ MilliporeSigma (Merck KGaA)

Headquarters: Burlington, Massachusetts, USA (Global Division)
Key Offering: Comprehensive catalog of Fmoc‑protected non‑natural amino acids, including (S)-N‑Fmoc‑3‑Bromophenylalanine

Merck’s MilliporeSigma leverages its extensive distribution network to provide rapid, high‑quality supply to CROs and academic labs worldwide. Its robust quality management system supports both research‑grade and GMP‑grade orders.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient manufacturing processes
• Development of custom synthesis services for rare halogenated amino acids
• Collaboration with biotech firms to accelerate peptide‑drug discovery

3️⃣ Watanabe Chemical Industries, Ltd.

Headquarters: Osaka, Japan
Key Offering: Advanced chiral resolution and Fmoc‑protection chemistry for specialty amino acids

Watanabe is renowned for its precision chiral synthesis capabilities, enabling the production of enantiomerically pure (S)-N‑Fmoc‑3‑Bromophenylalanine with high yield and purity. Its research partnerships focus on novel peptide therapeutics and chemical biology tools.

Sustainability & Growth Initiatives:

• Adoption of continuous flow synthesis to reduce solvent usage
• Investments in scalable chiral chromatography platforms
• Strategic alliances with contract manufacturing organizations

4️⃣ AAPPTec (Advanced Automated Peptide Protein Technologies)

Headquarters: Houston, Texas, USA
Key Offering: Automated peptide synthesis systems and custom amino acid synthesis services

AAPPTec provides end‑to‑end solutions for peptide synthesis, including on‑demand production of (S)-N‑Fmoc‑3‑Bromophenylalanine. Its focus on automation and process scalability positions it as a preferred partner for large‑scale peptide drug development.

Sustainability & Growth Initiatives:

• Integration of renewable energy sources in manufacturing facilities
• Development of high‑throughput synthesis platforms for rapid library generation
• Collaboration with pharmaceutical companies for lead optimization

5️⃣ Chem‑Impex International

Headquarters: Charlotte, North Carolina, USA
Key Offering: Custom synthesis of specialty amino acids, including halogenated derivatives

Chem‑Impex specializes in small‑batch, high‑purity synthesis for academic and industrial customers. Its flexible production schedule and rapid turnaround make it a go‑to supplier for niche reagents.

Sustainability & Growth Initiatives:

• Implementation of waste‑minimization protocols in synthesis
• Expansion of online ordering and technical support services
• Partnerships with CROs to support early‑stage peptide projects

6️⃣ Shanghai Haoyuan Chemexpress Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Competitive pricing for research‑scale quantities of halogenated Fmoc amino acids

Shanghai Haoyuan provides cost‑effective supply of (S)-N‑Fmoc‑3‑Bromophenylalanine to academic labs and CROs, leveraging its extensive Chinese manufacturing network.

Sustainability & Growth Initiatives:

• Adoption of green chemistry practices in production
• Development of rapid synthesis routes to reduce lead time
• Expansion of international distribution channels

7️⃣ Nanjing Peptide Biotech Co., Ltd.

Headquarters: Nanjing, China
Key Offering: Custom synthesis of halogenated and isotopically labeled amino acids

Nanjing Peptide Biotech focuses on delivering high‑purity reagents for advanced peptide research and drug discovery, with strong capabilities in chiral resolution.

Sustainability & Growth Initiatives:

• Implementation of continuous flow synthesis to improve efficiency
• Investment in analytical technologies for purity verification
• Collaboration with biotech startups for early‑stage pipeline development

8️⃣ Jiangsu Hengding Biotech Co., Ltd.

Headquarters: Yangzhou, China
Key Offering: Production of specialty amino acids with a focus on halogenated derivatives

Jiangsu Hengding offers reliable supply of (S)-N‑Fmoc‑3‑Bromophenylalanine with customizable purity grades and packaging options.

Sustainability & Growth Initiatives:

• Adoption of energy‑saving manufacturing processes
• Expansion of R&D to develop new halogenated amino acid libraries
• Strengthening of quality management systems for GMP compliance

9️⃣ Tokyo Chemical Industry Co., Ltd. (TCI)

Headquarters: Tokyo, Japan
Key Offering: High‑purity specialty chemicals and custom synthesis services

TCI’s expertise in fine chemical synthesis supports the production of (S)-N‑Fmoc‑3‑Bromophenylalanine with stringent purity and enantiomeric excess requirements.

Sustainability & Growth Initiatives:

• Development of solvent‑recycling systems in synthesis
• Investments in advanced chromatography for chiral resolution
• Partnerships with pharmaceutical companies for peptide‑drug development

🔟 Combi‑Blocks, Inc.

Headquarters: San Diego, California, USA
Key Offering: Comprehensive catalog of Fmoc‑protected amino acids and custom synthesis services

Combi‑Blocks offers a wide range of specialty amino acids, including (S)-N‑Fmoc‑3‑Bromophenylalanine, with a focus on high purity and rapid delivery to research labs and CROs.

Sustainability & Growth Initiatives:

• Implementation of eco‑friendly manufacturing practices
• Expansion of automated synthesis platforms for high‑throughput production
• Collaboration with academic institutions for advanced peptide research

---

Download FREE Sample Report: (S)-N-Fmoc-3-Bromophenylalanine (CAS 220497-48-3) Market – View in Detailed Research Report

Get Full Report: (S)-N-Fmoc-3-Bromophenylalanine (CAS 220497-48-3) Market – View in Detailed Research Report

---

Market Outlook

The global market for (S)-N‑Fmoc‑3‑Bromophenylalanine is projected to grow at a CAGR of 6.7% from 2026 to 2034, driven by the expansion of peptide‑based therapeutics, increased adoption of non‑natural amino acids, and the rise of bioconjugation chemistry. Key growth drivers include the development of stapled peptides, peptide‑drug conjugates, and PROTACs, all of which benefit from the unique reactivity of the meta‑bromine handle. Supply chain concentration in China and Europe is expected to remain a risk factor, but strategic partnerships with CDMOs and CROs will help mitigate lead‑time variability.

---

Future Trends

• Integration of AI‑driven peptide design tools to expand chemical space for halogenated amino acids.
• Growth of automated synthesis platforms enabling rapid library generation using (S)-N‑Fmoc‑3‑Bromophenylalanine.
• Increased focus on green chemistry and waste reduction in the production of specialty amino acids.
• Expansion of custom synthesis services for isotopically labeled and fluorinated analogs to support advanced proteomics and imaging studies.
• Continued regulatory support for GMP‑grade specialty reagents to accelerate clinical pipeline development.